Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Auriga Falls as Fungicide Sales Seen Dropping: Copenhagen Mover

Don't Miss Out —
Follow us on:

July 24 (Bloomberg) -- Auriga Industries A/S, the biggest Danish maker of chemicals for plant protection, fell in Copenhagen trading after its largest peer Syngenta AG said late European crop planting has weighed on demand for fungicides.

Auriga fell as much as 0.9 percent to 166.50 kroner and declined to 167 kroner at 10:05 a.m. local time. Trading volume was 8.6 percent of the three-month daily average. The stock underperformed the Nasdaq OMX Copenhagen all-share index which gained 0.7 percent.

Syngenta today reported sales and profits that missed analyst estimates and said a cold and wet European spring reduced the number of crop protection applications. Lemvig, Denmark-based Auriga, which is due to publish second-quarter earnings on Aug. 22, has beaten analyst sales estimates in nine of its last 12 quarterly reports, according to data compiled by Bloomberg.

“The report from Syngenta indicates a potential soft second quarter from Auriga,” Nordea Markets, a unit of Stockholm-based Nordea Bank AB, said in a note to clients today.

Basel, Switzerland-based Syngenta reported net income of $1.41 billion for the first half of the year, missing analyst estimates of $1.49 billion. The company’s shares fell as much as 4.2 percent in Zurich trading.

To contact the reporter on this story: Christian Wienberg in Copenhagen at cwienberg@bloomberg.net

To contact the editor responsible for this story: Tasneem Brogger at tbrogger@bloomberg.net

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.